Vertex's revenue was $2.96 billion in the second quarter of 2025, beating the consensus forecast by $58 million. Click here ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company has partnered with basketball world ...
Vertex Pharmaceuticals (VRTX) shares saw mild movement today, with the stock ticking slightly higher over the past week.
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
Decades of slow-moving research, along with broader failures of the healthcare system, have left millions of people in daily ...
Innovative obesity drugs. Quantum computing bits. A cystic fibrosis treatment. The scientists behind these discoveries could be among the 2025 Nobel Prize winners.
Type 1 Diabetes (T1D) disrupts the flow of daily life. You don’t drive your kids to school because you fear losing control of your car. You plan school and work and socializing around insulin ...
2don MSN
'Nanoreactor' cage uses visible light for catalytic and ultra-selective cross-cycloadditions
Researchers have engineered a novel M6L4 octahedral molecular cage by integrating photoactive cyclometalated platinum(II) ...
Finance is fast becoming one of the most high-impact areas for AI adoption. From anomaly detection to predictive compliance, today’s AI-powered tools help turn complexity into easily digestible data ...
Cystic fibrosis patients rarely used to see age 30. Now, with this Iowa doctor's work, people are living well into their 80s — and even running.
New data suggest antithymocyte globulin, verapamil, and baricitinib might help preserve beta cell function in new-onset type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback